Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All fluvoxamine studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchFluvoxamineFluvoxamine (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

COVID FAQ

Kirsch, S.
Mar 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
27th treatment shown to reduce risk in November 2021
 
*, now known with p = 0.00011 from 20 studies, recognized in 3 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19early.org
COVID FAQ from the founder of the COVID-19 Early Treatment Fund treatearly.org, including an extensive analysis of the fluvoxamine trials and other supporting evidence.
Reviews covering fluvoxamine for COVID-19 include Hashimoto, Hashimoto (B), Hashimoto (C), Hoertel, Kirsch, Sukhatme.
Kirsch et al., 6 Mar 2021, preprint, 1 author.
This PaperFluvoxamineAll
Abstract: COVID FAQ By Steve Kirsch Last updated: March 6, 2021 Disclaimer:​ The views expressed in this article are my own personal opinion based on my 1,000+ hour study of cutting edge research. The science is rapidly developing and this document may change over time. Please do not take any drugs or other actions mentioned in this article without seeking advice from a qualified medical professional. Table of Contents About this document Who are you? Why are you writing this? What do you recommend if I have COVID? I’m in the ICU with COVID. What should I do? What are the most important points to note other than the drugs and dosing? What do you recommend if I’ve had COVID, but still have symptoms, i.e, long-haul COVID? What is the fluvoxamine prescribing information? What are fluvoxamine drug interactions? When should I start the drugs? If I take the drugs, can I still die from COVID? I have low risk factors. Do I need to take any drugs? Is it legal for you to talk about using drugs for indications that aren’t approved by the FDA? If this is such a great treatment, why haven’t Stanford, Harvard, UCSF, and other institutions added this to their clinical practice guidelines? If this works so well, why haven’t I read extensively about it in the press? Shouldn’t everyone know? What is the evidence supporting fluvoxamine as a COVID treatment? Direct evidence Actual experience of doctors prescribing ivermectin who added FLV as a second drug Additional supporting evidence Page 1 Shouldn’t we wait for more evidence like the Phase 3 study results before doctors start prescribing this drug? Or wait for this to be on the NIH guidelines? NIH Director Francis Collins compared fluvoxamine with hydroxychloroquine on CNN. Is he wrong? What is the evidence for ivermectin? Are there any drugs that are as good as or better than fluvoxamine to treat COVID early? Does fluvoxamine help with COVID symptoms or just hospitalization risk? How does fluvoxamine work? What are the 8 mechanisms of action? What do infectious disease experts think? Have you applied for an EUA? Is there a Phase 3 clinical trial for fluvoxamine? Have other SSRIs been tested? Who else is writing about fluvoxamine? What’s the probability we save more lives if we start prescribing fluvoxamine? Where can I find out more information? Page 2 About this document This document contains answers to more detailed questions than I covered in the ​How I would treat COVID​ document. You should definitely read that document first. Who are you? I’m a serial entrepreneur and philanthropist and founder of ​COVID-19 Early Treatment Fund​. I’m a serial high-tech entrepreneur and philanthropist. I have started 7 high tech companies, two with billion dollar market caps. I have a SM and SB in EECS from MIT. More about me on Wikipedia​ and ​LinkedIn​. When the lockdown began, I took a leave of absence and started an organization, ​COVID-19 Early Treatment Fund​, that funds research on using repurposed drugs to treat COVID. We raised $5M, received 60 grant applications and funded 14. I chose that approach because I thought it would be the fastest and cheapest way to end the pandemic. Once we find a drug combination that reduces the hospitalization/death rate from COVID by more than a factor of 10, we should be able much more rapidly get back to normal. For more, watch this 3 minute intro: ​COVID-19 Early Treatment Fund (CETF) Introduction YouTube​. I was featured in a ​front page story in the LA Times​ about COVID..
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit